Seattle, WA, June 01, 2018 –(PR.com)– Blink Device Company announced today that it has received a CE Mark for TwitchView, its novel, user-friendly, quantitative monitor for neuromuscular blockade. With this certification, the company plans to launch the product into the European market, first appearing at the 2018 European Society of Anaesthesiology Annual Meeting in Copenhagen this weekend.

The current standard of care for monitoring neuromuscular blockade during surgery is peripheral nerve stimulation coupled with observation or accelerometry, technology that has not been improved for decades. TwitchView brings the assessment of neuromuscular blockade into the 21st century with reliable and accurate real-time electromyography-based monitoring that can support better drug dosing decisions and reversal timing – helping prevent residual neuromuscular blockade.

“At Blink Device Company, we aim to identify areas in medicine that can greatly benefit from technological innovation,” said CEO Justin Hulvershorn, M.D, Ph.D. “Neuromuscular blockade is ripe for such an advance. A typical response from clinicians who have used TwitchView is that it is like ‘turning on the lights in a dark room’. With remarkable ease-of-use, updating practices to benefit both practitioners and their patients is nearly effortless.”

About Twitch View

The TwitchView is an elegant response to the outdated and inadequate peripheral nerve stimulator. Utilizing advanced electromyography (EMG) to quantify a patient's depth of neuromuscular block, TwitchView provides clinicians with reliable and accurate real-time data to support drug dosing decisions and reversal timing, helping prevent residual neuromuscular blockade.

About Blink Device Company

Blink Device Company is redefining ease-of-use, dependability and accuracy within the medical device industry. Its first product is the TwitchView Quantitative Monitor for Neuromuscular Blockade. The company is headquartered in Seattle, Washington and their products are made in the USA. To learn more, visit www.blinkdc.com.

If you would like more information, please email Elise Hyman at [email protected]

Contact Information:
Blink Device Company
Elise Hyman
(312) 852-0064
Contact via Email
www.blinkdc.com

Read the full story here: https://www.pr.com/press-release/755500

Press Release Distributed by PR.com